Clinical trial · Observational
Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma
NCT00745862CI-TRIAL-00011474completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to examine the experiences and quality of life of women who have been treated for melanoma. By quality of life, we mean how they are feeling about different aspects of their life. In this study, we are especially interested in their feelings about survival, physical appearance and any family concerns. We will administer a series of QOL questionnaires, data sheets with many questions, to get their response to measure their feelings about these issues.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Melanoma | Melanoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| questionnaire on-line or if uncomfortable with a computer interface, paper copies will be provided | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- 1
- description
- female patients undergoing surgical treatment of cutaneous melanoma within two years of diagnosis and treatment
- interventionNames
- Behavioral: questionnaire on-line or if uncomfortable with a computer interface, paper copies will be provided
Primary outcomes (1)
- measure
- To measure illness related distress regarding survival, family planning and functioning, and aesthetic satisfaction and QOL in post-surgical female patients diagnosed with clinically localized primary cutaneous melanoma.
- timeFrame
- conclusion of study
Secondary outcomes (1)
- measure
- To examine the impact of illness related distress on QOL in women treated for clinically localized primary cutaneous melanoma.
- timeFrame
- conclusion of study
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age 18 years or older * Clinically node-negative primary cutaneous melanoma. * Patients participating must be female * Patients must have completed surgical treatment for melanoma at least 10 days ago and less than 2 years at the time of study entry. Exclusion Criteria: * Prior history of cancer with the exception of squamous or basal cell carcinoma of the skin.
References
Publications (1)
- DERIVEDAtkinson TM, Noce NS, Hay J, Rafferty BT, Brady MS. Illness-related distress in women with clinically localized cutaneous melanoma. Ann Surg Oncol. 2013 Feb;20(2):675-9. doi: 10.1245/s10434-012-2635-5. Epub 2012 Sep 11. PMID 22965568